The Rapid SARS-CoV-2 Antigen Test Card is a lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2. This test is authorized for home use with self-collected anterior nasal (nares) swab samples from individuals aged 14 years or older when tested twice over three days with at least 24 hours (and no more than 48 hours) between tests. The test is authorized for individuals with symptoms of COVID-19 within the first 6 days of symptom onset, or without symptoms or other epidemiological reasons to suspect COVID-19.
For more information, please visit the website: www.bosoncanada.com.
- Easy to use
- 3 different packaging options
- Authorized by Health Canada under Interim Order #346090
- Detect both Delta and Omicron Variant
- High accuracy
- Rapid result (15-20 minutes)
- Health Canada
- European Commission
- MHRA (UK)
- BfArM (Germany)